SAREPTA THERAPEUTICS, INC. Operating Income
SAREPTA THERAPEUTICS, INC. (SRPT) reported Operating Income of $13.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was $13.29M, a 88.50% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was $358.43M.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$411.58M, a 354.56% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$103.39M, a 565.80% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for fiscal 2025 was -$699.78M, a 420.88% decline from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for fiscal 2024 was $218.08M.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$267.82M.
- SAREPTA THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$536.20M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 371 month | Operating Income (Loss) 374 month | Operating Income (Loss) 377 month | Operating Income (Loss) 380 month | Operating Income (Loss) 383 month | Operating Income (Loss) 386 month | Operating Income (Loss) 389 month | Operating Income (Loss) 392 month | Operating Income (Loss) 395 month | Operating Income (Loss) 398 month | Operating Income (Loss) 401 month | Operating Income (Loss) 404 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $13.29M 10-Q · filed 2026-08-05 | $371.72M 10-Q · filed 2026-08-05 | -$39.86M derived: sum of 3 quarters · filed 2026-08-05 | -$143.25M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2026-03-31 | $358.43M 10-Q · filed 2026-05-06 | -$53.15M derived: sum of 2 quarters · filed 2026-05-06 | -$156.54M derived: sum of 3 quarters · filed 2026-05-06 | -$40.96M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-12-31 | -$411.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$514.97M derived: sum of 2 quarters · filed 2026-03-02 | -$399.39M derived: sum of 3 quarters · filed 2026-08-05 | -$699.78M 10-K · filed 2026-03-02 | ||||||||||||
| 2025-09-30 | -$103.39M 10-Q · filed 2025-11-06 | $12.19M derived: sum of 2 quarters · filed 2026-08-05 | -$288.20M 10-Q · filed 2025-11-06 | -$126.52M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-06-30 | $115.58M 10-Q · filed 2026-08-05 | -$184.81M 10-Q · filed 2026-08-05 | -$23.13M derived: sum of 3 quarters · filed 2026-08-05 | -$932.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||
| 2025-03-31 | -$300.39M 10-Q · filed 2026-05-06 | -$138.71M derived: sum of 2 quarters · filed 2026-05-06 | -$116.51M derived: sum of 3 quarters · filed 2026-05-06 | -$117.21M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||
| 2024-12-31 | $161.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $183.88M derived: sum of 2 quarters · filed 2026-03-02 | $183.18M derived: sum of 3 quarters · filed 2026-03-02 | $218.08M 10-K · filed 2026-03-02 | ||||||||||||
| 2024-09-30 | $22.20M 10-Q · filed 2025-11-06 | $21.50M derived: sum of 2 quarters · filed 2025-11-06 | $56.40M 10-Q · filed 2025-11-06 | $81.03M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-06-30 | -$701.00K 10-Q · filed 2025-08-06 | $34.20M 10-Q · filed 2025-08-06 | $58.83M derived: sum of 3 quarters · filed 2026-03-02 | $37.99M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-03-31 | $34.91M 10-Q · filed 2025-05-06 | $59.53M derived: sum of 2 quarters · filed 2026-03-02 | $38.69M derived: sum of 3 quarters · filed 2026-03-02 | -$94.83M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2023-12-31 | $24.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.78M derived: sum of 2 quarters · filed 2026-03-02 | -$129.74M derived: sum of 3 quarters · filed 2026-03-02 | -$267.82M 10-K · filed 2026-03-02 | ||||||||||||
| 2023-09-30 | -$20.84M 10-Q · filed 2024-11-06 | -$154.36M derived: sum of 2 quarters · filed 2024-11-06 | -$292.45M 10-Q · filed 2024-11-06 | -$399.28M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2023-06-30 | -$133.52M 10-Q · filed 2024-08-07 | -$271.61M 10-Q · filed 2024-08-07 | -$378.44M derived: sum of 3 quarters · filed 2025-02-28 | -$509.80M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2023-03-31 | -$138.09M 10-Q · filed 2024-05-01 | -$244.92M derived: sum of 2 quarters · filed 2025-02-28 | -$376.28M derived: sum of 3 quarters · filed 2025-02-28 | -$587.41M derived: sum of 4 quarters · filed 2025-02-28 | ||||||||||||
| 2022-12-31 | -$106.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$238.19M derived: sum of 2 quarters · filed 2025-02-28 | -$449.32M derived: sum of 3 quarters · filed 2025-02-28 | -$536.20M 10-K · filed 2025-02-28 | ||||||||||||
| 2022-09-30 | -$131.35M 10-Q · filed 2023-11-01 | -$342.49M derived: sum of 2 quarters · filed 2023-11-01 | -$429.37M 10-Q · filed 2023-11-01 | -$535.18M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | -$211.13M 10-Q · filed 2023-08-02 | -$298.01M 10-Q · filed 2023-08-02 | -$403.83M derived: sum of 3 quarters · filed 2024-02-28 | -$438.28M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | -$86.88M 10-Q · filed 2023-05-02 | -$192.69M derived: sum of 2 quarters · filed 2024-02-28 | -$227.15M derived: sum of 3 quarters · filed 2024-02-28 | -$394.73M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | -$105.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$140.27M derived: sum of 2 quarters · filed 2024-02-28 | -$307.85M derived: sum of 3 quarters · filed 2024-02-28 | -$459.71M 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | -$34.46M 10-Q · filed 2022-11-02 | -$202.03M derived: sum of 2 quarters · filed 2022-11-02 | -$353.90M 10-Q · filed 2022-11-02 | -$524.61M derived: sum of 4 quarters · filed 2022-11-02 | ||||||||||||
| 2021-06-30 | -$167.57M 10-Q · filed 2022-08-02 | -$319.44M 10-Q · filed 2022-08-02 | -$490.15M derived: sum of 3 quarters · filed 2022-08-02 | -$627.22M derived: sum of 4 quarters · filed 2022-08-02 | ||||||||||||
| 2021-03-31 | -$151.87M 10-Q · filed 2022-05-04 | -$322.58M derived: sum of 2 quarters · filed 2022-05-04 | -$459.65M derived: sum of 3 quarters · filed 2022-05-04 | -$598.00M derived: sum of 4 quarters · filed 2022-05-04 | ||||||||||||
| 2020-12-31 | -$170.72M 10-K · filed 2021-03-01 | -$307.78M derived: sum of 2 quarters · filed 2021-11-03 | -$446.14M derived: sum of 3 quarters · filed 2021-11-03 | -$564.16M 10-K · filed 2023-02-28 | ||||||||||||
| 2020-09-30 | -$137.07M 10-Q · filed 2021-11-03 | -$275.42M derived: sum of 2 quarters · filed 2021-11-03 | -$393.45M 10-Q · filed 2021-11-03 | -$623.67M derived: sum of 4 quarters · filed 2021-11-03 | ||||||||||||
| 2020-06-30 | -$138.35M 10-Q · filed 2021-08-04 | -$256.38M 10-Q · filed 2021-08-04 | -$486.60M derived: sum of 3 quarters · filed 2021-08-04 | -$610.19M derived: sum of 4 quarters · filed 2021-08-04 | ||||||||||||
| 2020-03-31 | -$118.03M 10-Q · filed 2021-05-05 | -$348.25M derived: sum of 2 quarters · filed 2021-05-05 | -$471.83M derived: sum of 3 quarters · filed 2021-05-05 | -$747.20M derived: sum of 4 quarters · filed 2021-05-05 | ||||||||||||
| 2019-12-31 | -$230.22M 10-K · filed 2021-03-01 | -$353.81M derived: sum of 2 quarters · filed 2021-03-01 | -$629.18M derived: sum of 3 quarters · filed 2021-03-01 | -$705.56M 10-K · filed 2022-03-01 | ||||||||||||
| 2019-09-30 | -$123.59M 10-K · filed 2021-03-01 | -$398.96M derived: sum of 2 quarters · filed 2021-03-01 | -$475.34M 10-Q · filed 2020-11-05 | -$614.71M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-06-30 | -$275.37M 10-K · filed 2021-03-01 | -$351.75M 10-Q · filed 2020-08-05 | -$491.12M derived: sum of 3 quarters · filed 2021-03-01 | -$561.22M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2019-03-31 | -$76.39M 10-K · filed 2021-03-01 | -$215.75M derived: sum of 2 quarters · filed 2021-03-01 | -$285.85M derived: sum of 3 quarters · filed 2021-03-01 | -$389.28M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||
| 2018-12-31 | -$139.36M 10-K · filed 2020-02-26 | -$209.46M derived: sum of 2 quarters · filed 2020-02-26 | -$312.89M derived: sum of 3 quarters · filed 2020-02-26 | -$343.63M 10-K · filed 2021-03-01 | ||||||||||||
| 2018-09-30 | -$70.10M 10-K · filed 2020-02-26 | -$173.53M derived: sum of 2 quarters · filed 2020-02-26 | -$204.26M 10-Q · filed 2019-11-07 | -$227.41M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2018-06-30 | -$103.43M 10-K · filed 2020-02-26 | -$134.17M 10-Q · filed 2019-08-07 | -$157.31M derived: sum of 3 quarters · filed 2020-02-26 | -$203.22M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2018-03-31 | -$30.74M 10-K · filed 2020-02-26 | -$53.89M derived: sum of 2 quarters · filed 2020-02-26 | -$99.79M derived: sum of 3 quarters · filed 2020-02-26 | -$163.13M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||||||
| 2017-12-31 | -$23.15M 10-K · filed 2019-02-28 | -$69.05M derived: sum of 2 quarters · filed 2019-02-28 | -$132.39M derived: sum of 3 quarters · filed 2019-02-28 | -$171.64M 10-K · filed 2020-02-26 | ||||||||||||
| 2017-09-30 | -$45.91M 10-K · filed 2019-02-28 | -$109.25M derived: sum of 2 quarters · filed 2019-02-28 | -$148.49M 10-Q · filed 2018-10-31 | -$236.89M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-06-30 | -$63.34M 10-K · filed 2019-02-28 | -$102.58M 10-Q · filed 2018-08-08 | -$190.98M derived: sum of 3 quarters · filed 2019-02-28 | -$247.51M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-03-31 | -$39.24M 10-K · filed 2019-02-28 | -$127.64M derived: sum of 2 quarters · filed 2019-02-28 | -$184.17M derived: sum of 3 quarters · filed 2019-02-28 | -$246.27M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2016-12-31 | -$88.39M 10-K · filed 2018-03-01 | -$144.93M derived: sum of 2 quarters · filed 2018-03-01 | -$207.03M derived: sum of 3 quarters · filed 2018-03-01 | -$266.73M 10-K · filed 2019-02-28 | ||||||||||||
| 2016-09-30 | -$56.53M 10-K · filed 2018-03-01 | -$118.63M derived: sum of 2 quarters · filed 2018-03-01 | -$178.34M 10-Q · filed 2017-11-01 | -$242.79M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2016-06-30 | -$62.10M 10-K · filed 2018-03-01 | -$121.80M 10-Q · filed 2017-08-03 | -$186.25M derived: sum of 3 quarters · filed 2018-03-01 | -$238.02M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2016-03-31 | -$59.70M 10-K · filed 2018-03-01 | -$124.15M derived: sum of 2 quarters · filed 2018-03-01 | -$175.92M derived: sum of 3 quarters · filed 2018-03-01 | -$218.02M derived: sum of 4 quarters · filed 2018-03-01 | ||||||||||||
| 2015-12-31 | -$64.45M 10-K · filed 2017-02-28 | -$116.22M derived: sum of 2 quarters · filed 2017-02-28 | -$158.32M derived: sum of 3 quarters · filed 2017-02-28 | -$220.18M 10-K · filed 2018-03-01 | ||||||||||||
| 2015-09-30 | -$51.76M 10-K · filed 2017-02-28 | -$93.87M derived: sum of 2 quarters · filed 2017-02-28 | -$155.73M 10-Q · filed 2016-11-07 | -$200.45M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2015-06-30 | -$42.11M 10-K · filed 2017-02-28 | -$103.97M 10-Q · filed 2016-08-09 | -$148.69M derived: sum of 3 quarters · filed 2017-02-28 | -$182.37M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2015-03-31 | -$61.86M 10-K · filed 2017-02-28 | -$106.58M derived: sum of 2 quarters · filed 2017-02-28 | -$140.26M derived: sum of 3 quarters · filed 2017-02-28 | -$170.53M derived: sum of 4 quarters · filed 2017-02-28 | ||||||||||||
| 2014-12-31 | -$44.72M 10-K · filed 2016-02-25 | -$78.40M derived: sum of 2 quarters · filed 2016-02-25 | -$108.67M derived: sum of 3 quarters · filed 2016-02-25 | -$133.79M 10-K · filed 2017-02-28 | ||||||||||||
| 2014-09-30 | -$33.67M 10-K · filed 2016-02-25 | -$63.95M derived: sum of 2 quarters · filed 2016-02-25 | -$89.07M 10-Q · filed 2015-11-05 | -$121.92M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||||
| 2014-06-30 | -$30.27M 10-K · filed 2016-02-25 | -$55.39M 10-Q · filed 2015-08-06 | -$88.24M derived: sum of 3 quarters · filed 2016-02-25 | -$113.17M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||||
| 2014-03-31 | -$25.12M 10-K · filed 2016-02-25 | -$57.97M derived: sum of 2 quarters · filed 2016-02-25 | -$82.90M derived: sum of 3 quarters · filed 2016-02-25 | -$99.99M derived: sum of 4 quarters · filed 2016-02-25 | -$476.07M 10-Q · filed 2014-05-08 | |||||||||||
| 2013-12-31 | -$32.85M 10-K · filed 2015-02-26 | -$57.78M derived: sum of 2 quarters · filed 2015-02-26 | -$74.87M derived: sum of 3 quarters · filed 2015-02-26 | -$90.28M 10-K · filed 2016-02-25 | -$450.95M 10-K · filed 2014-03-03 | |||||||||||
| 2013-09-30 | -$24.93M 10-Q · filed 2014-11-06 | -$42.02M derived: sum of 2 quarters · filed 2015-02-26 | -$57.44M 10-Q · filed 2014-11-06 | -$67.80M derived: sum of 4 quarters · filed 2015-02-26 | -$418.10M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | -$17.09M 10-K · filed 2015-02-26 | -$32.50M 10-Q · filed 2014-08-07 | -$42.87M derived: sum of 3 quarters · filed 2015-02-26 | -$49.77M derived: sum of 4 quarters · filed 2015-02-26 | -$393.17M 10-Q · filed 2013-08-08 | |||||||||||
| 2013-03-31 | -$15.41M 10-K · filed 2015-02-26 | -$25.78M derived: sum of 2 quarters · filed 2015-02-26 | -$32.69M derived: sum of 3 quarters · filed 2015-02-26 | -$38.24M derived: sum of 4 quarters · filed 2015-02-26 | -$376.08M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$10.37M 10-K · filed 2014-03-03 | -$17.27M derived: sum of 2 quarters · filed 2014-03-03 | -$22.83M derived: sum of 3 quarters · filed 2014-03-03 | -$29.70M 10-K · filed 2015-02-26 | -$360.67M 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | -$6.91M 10-K · filed 2014-03-03 | -$12.46M derived: sum of 2 quarters · filed 2014-03-03 | -$19.34M 10-Q · filed 2013-11-12 | -$28.34M derived: sum of 4 quarters · filed 2014-03-03 | -$350.30M 10-Q · filed 2012-11-07 | |||||||||||
| 2012-06-30 | -$5.56M 10-K · filed 2014-03-03 | -$12.43M 10-Q · filed 2013-08-08 | -$21.43M derived: sum of 3 quarters · filed 2014-03-03 | -$32.70M derived: sum of 4 quarters · filed 2014-03-03 | -$343.40M 10-Q · filed 2012-08-07 | |||||||||||
| 2012-03-31 | -$6.87M 10-K · filed 2014-03-03 | -$15.87M derived: sum of 2 quarters · filed 2014-03-03 | -$27.14M derived: sum of 3 quarters · filed 2014-03-03 | -$37.27M derived: sum of 4 quarters · filed 2014-03-03 | -$337.84M 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | -$9.00M 10-K · filed 2013-03-15 | -$20.27M derived: sum of 2 quarters · filed 2013-03-15 | -$30.40M derived: sum of 3 quarters · filed 2013-03-15 | -$35.93M 10-K · filed 2014-03-03 | -$330.96M 10-K · filed 2012-03-13 | |||||||||||
| 2011-09-30 | -$11.27M 10-K · filed 2013-03-15 | -$21.40M derived: sum of 2 quarters · filed 2013-03-15 | -$26.93M 10-Q · filed 2012-11-07 | -$28.67M derived: sum of 4 quarters · filed 2013-03-15 | -$321.96M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | -$10.13M 10-K · filed 2013-03-15 | -$15.66M 10-Q · filed 2012-08-07 | -$17.40M derived: sum of 3 quarters · filed 2013-03-15 | -$21.19M derived: sum of 4 quarters · filed 2013-03-15 | -$310.69M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | -$5.53M 10-K · filed 2013-03-15 | -$7.27M derived: sum of 2 quarters · filed 2013-03-15 | -$11.07M derived: sum of 3 quarters · filed 2013-03-15 | -$18.73M derived: sum of 4 quarters · filed 2013-03-15 | ||||||||||||
| 2010-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$5.54M derived: sum of 2 quarters · filed 2013-03-15 | -$13.20M derived: sum of 3 quarters · filed 2013-03-15 | -$20.93M 10-K · filed 2013-03-15 | ||||||||||||
| 2010-09-30 | -$3.80M 10-Q · filed 2011-11-08 | -$11.46M derived: sum of 2 quarters · filed 2011-11-08 | -$19.19M 10-Q · filed 2011-11-08 | |||||||||||||
| 2010-06-30 | -$7.67M 10-Q · filed 2011-08-08 | -$15.40M 10-Q · filed 2011-08-08 | ||||||||||||||
| 2009-12-31 | -$15.51M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |